Jakub Hlávka, Ph.D. is the Head of the Health Economics, Policy and Innovation Institute (HEPII) at Masaryk University, Czech Republic, and a Clinical Associate Professor (Adjunct) of Population and Public Health Sciences at the University of Southern California (USC). He is also a Non-Resident Fellow at the Leonard D. Schaeffer Center for Health Policy & Economics at USC.
Dr Hlávka's interests include Alzheimer's disease and the economics of aging, innovative payment for emerging therapies, incl. cell and gene therapies in oncology, neurology and cardiovascular disease, health system reform and the study of inequality, and resilience and preparedness of the healthcare system.
Prof. Hlávka holds a PhD from the Pardee RAND Graduate School, a master’s degree from Georgetown University, Edmund A. Walsh School of Foreign Service, and an undergraduate degree from the University of Economics in Prague.
